We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

THERMO FISHER SCIENTIFIC

  Gold Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Blood Abnormalities Found in People with Long Covid

By LabMedica International staff writers
Posted on 22 Aug 2022
Print article
Image: The Attune NxT Flow Cytometer is ideal for immunophenotyping and signaling studies, cell cycle analysis, detection of rare events, stem cell analysis, cancer and apoptosis studies, microbiological assays and more (Photo courtesy of Thermo Fisher Scientific).
Image: The Attune NxT Flow Cytometer is ideal for immunophenotyping and signaling studies, cell cycle analysis, detection of rare events, stem cell analysis, cancer and apoptosis studies, microbiological assays and more (Photo courtesy of Thermo Fisher Scientific).

SARS-CoV-2 infection can result in the development of a constellation of persistent sequelae following acute disease called post-acute sequelae of COVID-19 (PASC) or Long COVID.

The Long Covid patients, most of them struggling with intense fatigue, brain fog, and other symptoms, had low levels of cortisol, a stress hormone that helps the body control inflammation, glucose, sleep cycles. Long Covid shares certain features with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), another condition thought to follow an infection.

A large group of Imunobiologists at the Yale School of Medicine (New Haven, CT, USA) and their colleagues included 215 individuals in an exploratory, cross-sectional study to perform multi-dimensional immune phenotyping in conjunction with machine learning methods to identify key immunological features distinguishing Long COVID. The Healthy Controls (HC), Convalescent Controls (CC) and Long COVID (LC) groups had samples collected within the Mount Sinai Healthcare System (New York, NY, USA). The Healthcare Workers (HCW) group had samples collected within the Yale New Haven Healthcare System.

Whole blood was collected in sodium-heparin-coated vacutainers from participants at Mount Sinai Hospital. The following methods were implemented: Flow cytometry, prepared for analysis on an Attune NXT (Thermo Fisher Scientific, Waltham, MA, USA); SARS-CoV-2 antibody testing by ELISA plates were read at an excitation/emission wavelength of 450 nm and 570 nm; Multiplex proteomic analysis; Linear Peptide Profiling (Serimmune) and samples were normalized to a final concentration of 4 nM for each pool and run on the NextSeq500 (Illumina, San Diego, CA, USA); Protein-based Immunome Wide Association Study (PIWAS) analysis; IMUNE-based motif discovery; and Rapid Extracellular Antigen Profiling (REAP) and analysis.

The scientists reported that marked differences were noted in specific circulating myeloid and lymphocyte populations relative to matched control groups, as well as evidence of elevated humoral responses directed against SARS-CoV-2 among participants with Long COVID. Further, unexpected increases were observed in antibody responses directed against non-SARS-CoV-2 viral pathogens, particularly Epstein-Barr virus. Analysis of circulating immune mediators and various hormones also revealed pronounced differences, with levels of cortisol being uniformly lower among participants with Long COVID relative to matched control groups. The Long Covid blood samples were also awash with a category of “exhausted” T cells that can be recognized by certain markers they express. Such cells surge in the ongoing presence of pathogens, suggesting the bodies of people with Long Covid are actively fighting something.

The authors concluded that significant biological differences have been identified between participants with Long COVID and demographically and medically matched convalescent and healthy control groups, validating the extensive reports of persistent symptoms by various Long COVID advocacy groups. Unbiased machine learning models further identified both putative biomarkers of Long COVID, as well as potential mediators of Long COVID disease pathogenesis. The study was published on August 10, 2022 in the journal medRxiv.

Gold Supplier
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+
New
HPLC System
Jasper HPLC System
New
Human Anti-S. Cerevisiae Antibodies Test
ASCA-CHEK
New
TSI Stimulating Assay
Thyretain TSI Stimulating Reporter BioAssay

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Mindray ToRCH reagents deliver excellent seroconversion sensitivity (Photo courtesy of Mindray)

Mindray Launches High-Sensitivity and High-Specificity ToRCH Panel

Mindray (Shenzhen, China) has launched the ToRCH Panel that provides high-quality assays to meet different clinical needs. Thanks to the improved raw materials, processes, formulas, reaction models, and... Read more

Technology

view channel
Image: OneDraw Blood Collection Device significantly reduces obstacles for drawing blood (Photo courtesy of Drawbridge Health)

Near Pain-Free Blood Collection Technology Enables High-Quality Testing

Blood tests help doctors diagnose diseases and conditions such as cancer, diabetes, anemia, and coronary heart disease, as well as evaluate organ functionality. They can also be used to identify disease... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.